Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-09-22, Stock:LLY, The news for the past five days is as follows:
2021-09-15: NEWS1: Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval From MHLW.NEWS2: After Regeneron, US Government Orders Additional COVID-19 Therapy From Eli Lilly.NEWS3: The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs.NEWS4: UPDATE 1-U.S. buys additional doses of Eli Lilly, Regeneron COVID-19 therapy.NEWS5: Eli Lilly to supply the U.S. government with doses of COVID-19 treatment etesevimab for $330 million.NEWS6: Lilly to supply 388,000 doses of etesevimab to U.S. government for treatment of COVID-19.
2021-09-16: NEWS1: Emergency Use Authorization for Lilly's bamlanivimab and etesevimab administered together expanded to include post-exposure prophylaxis for COVID-19.NEWS2: UPDATE 1-FDA revises Lilly's COVID-19 antibody combo EUA for use after exposure to virus.NEWS3: FDA revises Lilly's COVID-19 antibody combo EUA for use after exposure to virus.NEWS4: Regeneron, Lilly Get New COVID Drug Deals From Government.
2021-09-17: NEWS1: Lilly (LLY) Gets FDA Nod for Expanded Use of COVID Cocktail.NEWS2: Pharma Stock Roundup: ABBV's Deal With RGNX, LLY COVID Drug's Government Order Win.
2021-09-20: NEWS1: Mirati (MRTX) Reports Positive Data From Colorectal Cancer Study.
2021-09-21: NEWS1: Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities.NEWS2: EU signs joint procurement deal for Eli Lilly COVID-19 treatment.NEWS3: UPDATE 1-Lilly to supply up to 220,000 COVID-19 antibody combo doses to European countries.NEWS4: Lilly announces procurement agreement with European Commission to supply bamlanivimab and etesevimab together for the treatment of confirmed COVID-19.NEWS5: Do Eli Lilly's (NYSE:LLY) Earnings Warrant Your Attention?.NEWS6: Lilly Announces the Early Tender Results of Its Pending Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities and Removal of the Note Caps for Its 3.950% Notes due 2049 and Its 4.150% Notes due 2059.

Answer: Decrease